telmisartan has been researched along with Proteinuria in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (45.00) | 29.6817 |
| 2010's | 17 (42.50) | 24.3611 |
| 2020's | 5 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cianciolo, RE; Di Bella, A; Peak, K; Travail, V | 1 |
| Akabane, R; Miyagawa, Y; Miyakawa, H; Nagakawa, M; Ogawa, M; Sakatani, A; Takemura, N | 1 |
| Brown, SA; Coleman, AE; Creevy, KE; Lourenço, BN; Parkanzky, MC; Schmiedt, CW | 1 |
| Fowler, BL; Hess, RS; McGonigle, K; Stefanovski, D | 1 |
| Fifle, L; Javard, R; Lecavalier, J | 1 |
| Kang, SS; Kim, HJ; Kwon, YJ; Suh, GH | 1 |
| Cai, G; Chen, X; Guan, X; Li, J; Li, W; Liu, M; Liu, W; Liu, Y; Lun, L; Wang, Y; Wu, H; Yao, H; Yin, S; Zhang, J; Zheng, Y; Zhou, C; Zhu, H; Zhuang, X | 1 |
| Albayrak, B; Bilen, Y; Cankaya, E; Cerrah, S; Cetinkaya, R | 1 |
| El-Kadem, AH; El-Mahdy, NA; El-Sayad, ME | 1 |
| Bi, G; Cao, K; Fang, D; He, Y; Li, Z; Song, X; Wang, F; Wei, Y; Wu, J; Yang, J; Zhang, Z | 1 |
| Budaj, A; Chaithiraphan, S; Dickstein, K; Dyal, L; Keltai, M; Maggioni, A; Mann, JF; McQueen, M; Metsärinne, K; Oto, A; Parkhomenko, A; Piegas, LS; Pogue, J; Schmieder, RE; Schumacher, H; Svendsen, TL; Teo, KK; Wang, X; Yusuf, S | 1 |
| Damodar, A; Panesar, M | 1 |
| Inoue, T; Kawagoe, Y; Nakamura, T; Node, K; Sugaya, T; Suzuki, T; Ueda, Y | 1 |
| Chan, CM; Wong, KS; Woo, KT | 1 |
| Aleksandrowicz, E; Larczyński, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 2 |
| Bichu, P; Khan, A; Nistala, R; Sowers, JR; Whaley-Connell, A | 1 |
| Chaisuvannarat, V; Krairittichai, U | 1 |
| Bakris, GL; Kalaitzidis, R | 1 |
| Remuzzi, G; Ruggenenti, P | 1 |
| Azuma, K; Dejima, T; Kanaoka, T; Maeda, A; Masuda, S; Ohsawa, M; Tamura, K; Umemura, S; Wakui, H; Yanagi, M | 1 |
| Hamada, M; Hitomi, H; Imanishi, M; Kishida, M; Kobori, H; Konishi, Y; Maeda, I; Morikawa, T; Nagai, Y; Nakagawa, T; Nakano, D; Nishiyama, A; Ohashi, N; Okumura, M | 1 |
| Abe, M; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K | 1 |
| Fujiwara, N; Kawagoe, Y; Koide, H; Nakamura, T; Sugaya, T; Ueda, Y | 1 |
| Chen, C; Ding, G; Hu, F; Liang, W; Ren, Z; Shi, J; Singhal, PC; van Goor, H | 1 |
| Falasca, K; Mancino, P; Pizzigallo, E; Ucciferri, C; Vecchiet, J | 1 |
| Grassi, B; Neumann, I | 1 |
| Goto, SN; Iwata, K; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
| Balakumar, P; Bishnoi, HK; Mahadevan, N | 1 |
| Arumugam, S; Harima, M; Kawachi, H; Lakshmanan, AP; Sari, FR; Soetikno, V; Suzuki, K; Watanabe, K | 1 |
| Boor, P; Cohen, CD; Denecke, B; Eitner, F; Floege, J; Gan, L; Konieczny, A; Kunter, U; Neusser, MA; Ostendorf, T; Scholl, T; van Roeyen, CR; Villa, L | 1 |
| Bednarski, R; Donderski, R; Heleniak, Z; Lizakowski, S; Manitius, J; Przybylska, M; Renke, M; Rutkowski, B; Rutkowski, P; Sulikowska, B; Tylicki, L | 1 |
| Merta, M; Rysavá, R; Tesar, V | 1 |
| Aranda, FJ; Aranda, P; Frutos, MA; López de Novales, E; López, V; Ruilope, LM; Segura, J | 1 |
| Barnett, A | 1 |
| Chachin, M; Hayashi, N; Hayashi, T; Horie, Y; Konomi, A; Matsumaru, T; Ohmura, T; Seidler, R; Sumida, T; Tsunenari, I | 1 |
| Böger, RH; Galle, J; Pinnetti, S; Schwedhelm, E; Wanner, C | 1 |
| Bakris, G; Burgess, E; Davidai, G; Koval, S; Weir, M | 1 |
| Balduini, CL; Fiore, CE; Granata, A; Pecci, A | 1 |
| Audeval-Gerard, C; Champeroux, P; Richard, S; Wienen, W | 1 |
3 review(s) available for telmisartan and Proteinuria
| Article | Year |
|---|---|
Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Hemodynamics; Humans; Losartan; Mineralocorticoid Receptor Antagonists; PPAR gamma; Proteinuria; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2009 |
Effects of telmisartan on proteinuria or albuminuria: a meta-analysis of randomized trials.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Humans; Proteinuria; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2013 |
Prevention of loss of renal function over time in patients with diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Agents; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan; Time Factors; Treatment Outcome | 2006 |
16 trial(s) available for telmisartan and Proteinuria
| Article | Year |
|---|---|
Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double-masked, randomized clinical trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Dog Diseases; Dogs; Prospective Studies; Proteinuria; Telmisartan; Treatment Outcome | 2020 |
Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study.
Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Benzimidazoles; Benzoates; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperkalemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Probucol; Proteinuria; Telmisartan; Treatment Outcome | 2016 |
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney; Middle Aged; Proteinuria; Ramipril; Telmisartan | 2008 |
Renoprotective effect of telmisartan in patients with chronic kidney disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Collagen Type IV; Creatinine; Fatty Acid-Binding Proteins; Female; Glomerular Filtration Rate; Heart Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Telmisartan; Time Factors | 2008 |
Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cilazapril; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrosis; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Peptide Fragments; Procollagen; Proteinuria; Renin; Renin-Angiotensin System; Telmisartan; Young Adult | 2008 |
Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
Topics: Adult; Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Synergism; Drug Therapy, Combination; Enalapril; Female; Humans; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2009 |
Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Ankle Brachial Index; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Diabetic Nephropathies; Double-Blind Method; Electrocardiography; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Proteinuria; Regression Analysis; Telmisartan; Young Adult | 2009 |
Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Telmisartan | 2010 |
Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Enalapril; Endothelin-1; Fatty Acid-Binding Proteins; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Proteinuria; Telmisartan | 2010 |
[Critically appraised article].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Middle Aged; Multicenter Studies as Topic; Proteinuria; Ramipril; Telmisartan | 2012 |
The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?.
Topics: Adult; Albuminuria; Amides; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Comorbidity; Cross-Over Studies; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Eplerenone; Female; Fumarates; Humans; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Severity of Illness Index; Spironolactone; Telmisartan; Treatment Outcome | 2012 |
Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Proteinuria; Severity of Illness Index; Telmisartan | 2005 |
Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Creatinine; Dose-Response Relationship, Drug; Dyslipidemias; Female; Follow-Up Studies; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Topics: Acetylglucosaminidase; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Collagen Type III; Cross-Over Studies; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Potassium; Proteinuria; Renin-Angiotensin System; Spironolactone; Telmisartan | 2008 |
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Proteinuria; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 2008 |
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Half-Life; Humans; Hypertension; Losartan; Male; Middle Aged; Proteinuria; Telmisartan | 2008 |
21 other study(ies) available for telmisartan and Proteinuria
| Article | Year |
|---|---|
Mycophenolate mofetil and telmisartan for the treatment of proteinuria secondary to minimal change disease podocytopathy in a dog.
Topics: Animals; Dog Diseases; Dogs; Female; Kidney Glomerulus; Mycophenolic Acid; Nephrosis, Lipoid; Proteinuria; Telmisartan | 2022 |
Effects of telmisartan on proteinuria and systolic blood pressure in dogs with chronic kidney disease.
Topics: Animals; Blood Pressure; Dog Diseases; Dogs; Female; Male; Proteinuria; Renal Insufficiency, Chronic; Retrospective Studies; Telmisartan; Treatment Outcome | 2020 |
Effect of telmisartan, angiotensin-converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blood Pressure; Dog Diseases; Dogs; Proteinuria; Telmisartan | 2021 |
Treatment of proteinuria in dogs with telmisartan: A retrospective study.
Topics: Animals; Creatinine; Dog Diseases; Dogs; Proteinuria; Retrospective Studies; Telmisartan | 2021 |
Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine.
Topics: Amlodipine; Animals; Antihypertensive Agents; Carcinoma, Renal Cell; Dog Diseases; Dogs; Hypertension; Kidney Neoplasms; Male; Nephroureterectomy; Proteinuria; Telmisartan | 2018 |
The effects of dual and triple combinations of trandolapril, telmisartan, and verapamil on overt proteinuria in the patients with diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Proteinuria; Telmisartan; Verapamil; Young Adult | 2016 |
Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
Topics: Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Urea Nitrogen; Body Weight; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Glycation End Products, Advanced; Interleukin-1beta; Kidney; Nitric Oxide; Proteinuria; Rats; Sildenafil Citrate; Streptozocin; Superoxide Dismutase; Telmisartan; Transforming Growth Factor beta1 | 2016 |
Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Down-Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Kidney; Male; Nephritis; NF-kappa B; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Telmisartan; Transforming Growth Factor beta | 2017 |
Aliskiren combined with losartan in diabetes and nephropathy.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Therapy, Combination; Fumarates; Humans; Losartan; Proteinuria; Renin; Telmisartan | 2008 |
Telmisartan is more effective than losartan in reducing proteinuria.
Topics: Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetic Nephropathies; Humans; Losartan; Proteinuria; Telmisartan; Treatment Outcome | 2009 |
Effects of angiotensin II receptor blockers on diabetic nephropathy.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetic Neuropathies; Disease Progression; Humans; Kaplan-Meier Estimate; Kidney; Proteinuria; Telmisartan | 2009 |
Proteinuria: Is the ONTARGET renal substudy actually off target?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney; Multicenter Studies as Topic; Proteinuria; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2009 |
Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Drug Synergism; Eplerenone; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Podocytes; Proteinuria; Rats; Rats, Inbred OLETF; Spironolactone; Telmisartan | 2010 |
Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats.
Topics: Albuminuria; Aldosterone; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Benzimidazoles; Benzoates; Blotting, Western; Calcium Channel Blockers; Eplerenone; Immunoenzyme Techniques; Kidney Glomerulus; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Telmisartan | 2011 |
Proteinuria in an African HIV-infected patient: effects of telmisartan.
Topics: Africa; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; HIV Infections; Humans; Male; Middle Aged; Proteinuria; Telmisartan | 2011 |
The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Creatine; Diabetes Mellitus; Diabetic Nephropathies; Drug Therapy, Combination; Female; Fenofibrate; Hypolipidemic Agents; Kidney; Lipids; Male; Nitrogen; Oxidative Stress; PPAR alpha; Proteinuria; Rats; Rats, Wistar; Streptozocin; Telmisartan | 2012 |
Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway.
Topics: Animals; Benzimidazoles; Benzoates; Blood Pressure; Blood Urea Nitrogen; Creatinine; Curcumin; Cyclooxygenase 2; Fibronectins; Fibrosis; Heme Oxygenase (Decyclizing); Inflammation; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Kidney; Kidney Diseases; Male; Nephrectomy; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Signal Transduction; Telmisartan; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2013 |
Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cell Dedifferentiation; Cell Line; Chemokine CCL20; Cytoprotection; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Inflammation; Isoantibodies; Macrophages; Male; Mice; Nephrectomy; Podocytes; Proteinuria; Rats; Rats, Wistar; Receptors, CCR6; Receptors, Platelet-Derived Growth Factor; RNA Interference; RNA, Messenger; Telmisartan; Time Factors; Transfection | 2013 |
Renoprotective effects of telmisartan on renal injury in obese Zucker rats.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Male; Proteinuria; Rats; Rats, Zucker; Telmisartan; Triglycerides; Urine | 2012 |
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cataract; Female; Hearing Loss, Sensorineural; Humans; Kidney Diseases; Losartan; Male; Molecular Motor Proteins; Mutation; Myosin Heavy Chains; Proteinuria; Ramipril; Renin-Angiotensin System; Syndrome; Telmisartan; Thrombocytopenia | 2008 |
Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hyperglycemia; Hypertension; Kidney; Kidney Glomerulus; Lisinopril; Male; Organ Size; Proteinuria; Rats; Rats, Inbred SHR; Reference Values; Telmisartan | 2001 |